Research Confirms Better Oil from New DuPont High Oleic Soy... (demandfor nutritionally improved oils an...)

Research Confirms Better Oil from New DuPont High Oleic Soybean Trait

Date:3/18/2008

demand for nutritionally improved oils and provide valuable contracting opportunities for farmers."

In addition to delivering at least 80 percent oleic acid, the high oleic soybean oil trait has consistently demonstrated a linolenic acid content of less than 3 percent, and over 20 percent less saturated fatty acids than commodity soybean oil.

The oil will be available to food companies for testing following the 2008 growing season. This will allow food industry customers to conduct independent high oleic soybean oil testing in advance of commercial quantities being available after the 2009 soybean harvest.

The high oleic soybean oil produced from Pioneer(R) brand soybean varieties will be marketed as TREUS(R) High Oleic Soybean Oil. The TREUS(TM) brand name represents the industry-leading family of soy products developed as part of the Bunge DuPont Biotech Alliance. The high oleic soybean oil trait is on track for 2009 commercial introduction in the United States, pending regulatory approvals.

The Bunge DuPont Biotech Alliance was formed in 2003 to continue research and commercialize value-added soybean output traits developed through Pioneer soybean research and marketed through Bunge North America.

Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), is a vertically integrated food and feed ingredient company, supplying raw and processed agricultural commodities and specialized food ingredients to a wide range of customers in the livestock, poultry, food processor, foodservice and bakery industries. With headquarters in St. Louis, Missouri, Bunge North America and its subsidiaries operate grain elevators, oilseed processing plants, edible oil refineries and packaging facilities, an
'/>"/>

1

GOOD

Page: 1 2 3
Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year

Post Your Comments:

Research Confirms Better Oil from New DuPont High Oleic Soy...(demandfor nutritionally improved oils an...)